{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:28:56Z","timestamp":1791250136231,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"22","license":[{"start":{"date-parts":[[2014,8,4]],"date-time":"2014-08-04T00:00:00Z","timestamp":1407110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,8,4]],"date-time":"2014-08-04T00:00:00Z","timestamp":1407110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2015,5,28]]},"DOI":"10.1038\/onc.2014.230","type":"journal-article","created":{"date-parts":[[2014,8,4]],"date-time":"2014-08-04T10:08:11Z","timestamp":1407146891000},"page":"2943-2948","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Mice engineered for an obligatory Mdm4 exon skipping express higher levels of the Mdm4-S isoform but exhibit increased p53 activity"],"prefix":"10.1038","volume":"34","author":[{"given":"B","family":"Bardot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Bouarich-Bourimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Leemput","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Lejour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Hamon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Plancke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A G","family":"Jochemsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Simeonova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Toledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,4]]},"reference":[{"key":"BFonc2014230_CR1","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/nrc2012","volume":"6","author":"F Toledo","year":"2006","unstructured":"Toledo F, Wahl GM . Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat Rev Cancer 2006; 6: 909\u2013923.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2014230_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/B978-0-12-380916-2.00003-6","volume":"94","author":"JC Marine","year":"2011","unstructured":"Marine JC . MDM2 and MDMX in cancer and development. Curr Top Dev Biol 2011; 94: 45\u201375.","journal-title":"Curr Top Dev Biol"},{"key":"BFonc2014230_CR3","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.ccr.2006.03.014","volume":"9","author":"F Toledo","year":"2006","unstructured":"Toledo F, Krummel KA, Lee CJ, Liu CW, Rodewald LW, Tang M et al. A mouse p53 mutant lacking the proline rich domain rescues Mdm4 deficiency and provides insight into the Mdm2-Mdm4-p53 regulatory network. Cancer Cell 2006; 9: 273\u2013285.","journal-title":"Cancer Cell"},{"key":"BFonc2014230_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature05194","volume":"444","author":"NA Laurie","year":"2006","unstructured":"Laurie NA, Donovan SL, Shih CS, Zhang J, Mills N, Fuller C et al. Inactivation of the p53 pathway in retinoblastoma. Nature 2006; 444: 61\u201366.","journal-title":"Nature"},{"key":"BFonc2014230_CR5","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.ccr.2010.10.024","volume":"18","author":"F Bernal","year":"2010","unstructured":"Bernal F, Wade M, Godes M, Davis TN, Whitehead DG, Kung AL et al. A stapled p53 helix overcomes HDMX-mediated suppression of p53. Cancer Cell 2010; 18: 411\u2013422.","journal-title":"Cancer Cell"},{"key":"BFonc2014230_CR6","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1101\/gad.16722111","volume":"25","author":"D Garcia","year":"2011","unstructured":"Garcia D, Warr MR, Martins CP, Brown Swigart L, Passegue E, Evan GI et al. Validation of MdmX as a therapeutic target for reactivating p53 in tumors. Genes Dev 2011; 25: 1746\u20131757.","journal-title":"Genes Dev"},{"key":"BFonc2014230_CR7","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/nm.2863","volume":"18","author":"A Gembarska","year":"2012","unstructured":"Gembarska A, Luciani F, Fedele C, Russell EA, Dewaele M, Villar S et al. MDM4 is a key therapeutic target in cutaneous melanoma. Nat Med 2012; 18: 1239\u20131247.","journal-title":"Nat Med"},{"key":"BFonc2014230_CR8","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/onc.2013.62","volume":"33","author":"M Fang","year":"2014","unstructured":"Fang M, Simeonova I, Bardot B, Lejour V, Jaber S, Bouarich-Bourimi R et al. Mdm4 loss in mice expressing a p53 hypomorph alters tumor spectrum without improving survival. Oncogene 2014; 33: 1336\u20131339.","journal-title":"Oncogene"},{"key":"BFonc2014230_CR9","doi-asserted-by":"publisher","first-page":"42","DOI":"10.2174\/138920209787581280","volume":"10","author":"F Mancini","year":"2009","unstructured":"Mancini F, Di Conza G, Moretti F . MDM4 (MDMX) and its transcript variants. Curr Genomics 2009; 10: 42\u201350.","journal-title":"Curr Genomics"},{"key":"BFonc2014230_CR10","doi-asserted-by":"publisher","first-page":"29111","DOI":"10.1074\/jbc.M110.129726","volume":"285","author":"A Phillips","year":"2010","unstructured":"Phillips A, Teunisse A, Lam S, Lodder K, Darley M, Emaduddin M et al. HDMX-L is expressed from a functional p53-responsive promoter in the first intron of the HDMX gene and participates in an autoregulatory feedback loop to control p53 activity. J Biol Chem 2010; 285: 29111\u201329127.","journal-title":"J Biol Chem"},{"key":"BFonc2014230_CR11","doi-asserted-by":"publisher","first-page":"8299","DOI":"10.1074\/jbc.274.12.8299","volume":"274","author":"R Rallapalli","year":"1999","unstructured":"Rallapalli R, Strachan G, Cho B, Mercer WE, Hall DJ . A novel MDMX transcript expressed in a variety of transformed cell lines encodes a truncated protein with potent p53 repressive activity. J Biol Chem 1999; 274: 8299\u20138308.","journal-title":"J Biol Chem"},{"key":"BFonc2014230_CR12","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1002\/ijc.11023","volume":"104","author":"MJ Riemenschneider","year":"2003","unstructured":"Riemenschneider MJ, Knobbe CB, Reifenberger G . Refined mapping of 1q32 amplicons in malignant gliomas confirms MDM4 as the main amplification target. Int J Cancer 2003; 104: 752\u2013757.","journal-title":"Int J Cancer"},{"key":"BFonc2014230_CR13","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/ijc.21206","volume":"117","author":"F Bartel","year":"2005","unstructured":"Bartel F, Schulz J, Bohnke A, Blumke K, Kappler M, Bache M et al. Significance of HDMX-S (or MDM4) mRNA splice variant overexpression and HDMX gene amplification on primary soft tissue sarcoma prognosis. Int J Cancer 2005; 117: 469\u2013475.","journal-title":"Int J Cancer"},{"key":"BFonc2014230_CR14","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s00109-008-0322-6","volume":"86","author":"A Prodosmo","year":"2008","unstructured":"Prodosmo A, Giglio S, Moretti S, Mancini F, Barbi F, Avenia N et al. Analysis of human MDM4 variants in papillary thyroid carcinomas reveals new potential markers of cancer properties. J Mol Med 2008; 86: 585\u2013596.","journal-title":"J Mol Med"},{"key":"BFonc2014230_CR15","doi-asserted-by":"publisher","first-page":"4074","DOI":"10.1158\/0008-5472.CAN-12-0215","volume":"72","author":"K Lenos","year":"2012","unstructured":"Lenos K, Grawenda AM, Lodder K, Kuijjer ML, Teunisse AF, Repapi E et al. Alternate splicing of the p53 inhibitor HDMX offers a superior prognostic biomarker than p53 mutation in human cancer. Cancer Res 2012; 72: 4074\u20134084.","journal-title":"Cancer Res"},{"key":"BFonc2014230_CR16","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/jcb.10535","volume":"89","author":"R Rallapalli","year":"2003","unstructured":"Rallapalli R, Strachan G, Tuan RS, Hall DJ . Identification of a domain within MDMX-S that is responsible for its high affinity interaction with p53 and high-level expression in mammalian cells. J Cell Biochem 2003; 89: 563\u2013575.","journal-title":"J Cell Biochem"},{"key":"BFonc2014230_CR17","doi-asserted-by":"publisher","first-page":"17814","DOI":"10.1073\/pnas.1317398110","volume":"110","author":"M Bista","year":"2013","unstructured":"Bista M, Petrovich M, Fersht AR . MDMX contains an autoinhibitory sequence element. Proc Natl Acad Sci USA 2013; 110: 17814\u201317819.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2014230_CR18","doi-asserted-by":"publisher","first-page":"876173","DOI":"10.1155\/2011\/876173","volume":"2011","author":"K Lenos","year":"2011","unstructured":"Lenos K, Jochemsen AG . Functions of MDMX in the modulation of the p53-response. J Biomed Biotechnol 2011; 2011: 876173.","journal-title":"J Biomed Biotechnol"},{"key":"BFonc2014230_CR19","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1101\/gad.219899.113","volume":"27","author":"M Bezzi","year":"2013","unstructured":"Bezzi M, Teo SX, Muller J, Mok WC, Sahu SK, Vardy LA et al. Regulation of constitutive and alternative splicing by PRMT5 reveals a role for Mdm4 pre-mRNA in sensing defects in the spliceosomal machinery. Genes Dev 2013; 27: 1903\u20131916.","journal-title":"Genes Dev"},{"key":"BFonc2014230_CR20","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/ng714","volume":"29","author":"J Parant","year":"2001","unstructured":"Parant J, Chavez-Reyes A, Little NA, Yan W, Reinke V, Jochemsen AG et al. Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53. Nat Genet 2001; 29: 92\u201395.","journal-title":"Nat Genet"},{"key":"BFonc2014230_CR21","doi-asserted-by":"publisher","first-page":"5527","DOI":"10.1128\/MCB.22.15.5527-5538.2002","volume":"22","author":"D Migliorini","year":"2002","unstructured":"Migliorini D, Denchi EL, Danovi D, Jochemsen A, Capillo M, Gobbi A et al. Mdm4 (Mdmx) regulates p53-induced growth arrest and neuronal cell death during early embryonic mouse development. Mol Cell Biol 2002; 22: 5527\u20135538.","journal-title":"Mol Cell Biol"},{"key":"BFonc2014230_CR22","first-page":"3221","volume":"62","author":"RA Finch","year":"2002","unstructured":"Finch RA, Donoviel DB, Potter D, Shi M, Fan A, Freed DD et al. mdmx is a negative regulator of p53 activity in vivo. Cancer Res 2002; 62: 3221\u20133225.","journal-title":"Cancer Res"},{"key":"BFonc2014230_CR23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ccr.2009.05.008","volume":"16","author":"YV Wang","year":"2009","unstructured":"Wang YV, Leblanc M, Wade M, Jochemsen AG, Wahl GM . Increased radioresistance and accelerated B cell lymphomas in mice with Mdmx mutations that prevent modifications by DNA-damage-activated kinases. Cancer Cell 2009; 16: 33\u201343.","journal-title":"Cancer Cell"},{"key":"BFonc2014230_CR24","doi-asserted-by":"publisher","first-page":"11995","DOI":"10.1073\/pnas.1102241108","volume":"108","author":"V Pant","year":"2011","unstructured":"Pant V, Xiong S, Iwakuma T, Quintas-Cardama A, Lozano G . Heterodimerization of Mdm2 and Mdm4 is critical for regulating p53 activity during embryogenesis but dispensable for p53 and Mdm2 stability. Proc Natl Acad Sci USA 2011; 108: 11995\u201312000.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2014230_CR25","doi-asserted-by":"publisher","first-page":"12001","DOI":"10.1073\/pnas.1102309108","volume":"108","author":"L Huang","year":"2011","unstructured":"Huang L, Yan Z, Liao X, Li Y, Yang J, Wang ZG et al. The p53 inhibitors MDM2\/MDMX complex is required for control of p53 activity in vivo. Proc Natl Acad Sci USA 2011; 108: 12001\u201312006.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2014230_CR26","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/0092-8674(93)90719-7","volume":"74","author":"SW Lowe","year":"1993","unstructured":"Lowe SW, Ruley HE, Jacks T, Housman DE . p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993; 74: 957\u2013967.","journal-title":"Cell"},{"key":"BFonc2014230_CR27","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1016\/j.celrep.2013.05.028","volume":"3","author":"I Simeonova","year":"2013","unstructured":"Simeonova I, Jaber S, Draskovic I, Bardot B, Fang M, Bouarich-Bourimi R et al. Mutant mice lacking the p53 C-terminal domain model telomere syndromes. Cell Rep 2013; 3: 2046\u20132058.","journal-title":"Cell Rep"},{"key":"BFonc2014230_CR28","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1101\/gad.2024411","volume":"25","author":"YV Wang","year":"2011","unstructured":"Wang YV, Leblanc M, Fox N, Mao JH, Tinkum KL, Krummel K et al. Fine-tuning p53 activity through C-terminal modification significantly contributes to HSC homeostasis and mouse radiosensitivity. Genes Dev 2011; 25: 1426\u20131438.","journal-title":"Genes Dev"},{"key":"BFonc2014230_CR29","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1101\/gad.233585.113","volume":"28","author":"N Okada","year":"2014","unstructured":"Okada N, Lin CP, Ribeiro MC, Biton A, Lai G, He X et al. A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression. Genes Dev 2014; 28: 438\u2013450.","journal-title":"Genes Dev"},{"key":"BFonc2014230_CR30","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/sj.onc.1206925","volume":"23","author":"HA Steinman","year":"2004","unstructured":"Steinman HA, Sluss HK, Sands AT, Pihan G, Jones SN . Absence of p21 partially rescues Mdm4 loss and uncovers an antiproliferative effect of Mdm4 on cell growth. Oncogene 2004; 23: 303\u2013306.","journal-title":"Oncogene"},{"key":"BFonc2014230_CR31","doi-asserted-by":"publisher","first-page":"7935","DOI":"10.1038\/sj.onc.1208930","volume":"24","author":"HA Steinman","year":"2005","unstructured":"Steinman HA, Hoover KM, Keeler ML, Sands AT, Jones SN . Rescue of Mdm4-deficient mice by Mdm2 reveals functional overlap of Mdm2 and Mdm4 in development. Oncogene 2005; 24: 7935\u20137940.","journal-title":"Oncogene"},{"key":"BFonc2014230_CR32","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1128\/MCB.01108-07","volume":"28","author":"Z Matijasevic","year":"2008","unstructured":"Matijasevic Z, Steinman HA, Hoover K, Jones SN . MdmX promotes bipolar mitosis to suppress transformation and tumorigenesis in p53-deficient cells and mice. Mol Cell Biol 2008; 28: 1265\u20131273.","journal-title":"Mol Cell Biol"},{"key":"BFonc2014230_CR33","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/ncb2641","volume":"15","author":"PA Muller","year":"2013","unstructured":"Muller PA, Vousden KH . p53 mutations in cancer. Nat Cell Biol 2013; 15: 2\u20138.","journal-title":"Nat Cell Biol"},{"key":"BFonc2014230_CR34","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S1470-2045(07)70104-3","volume":"8","author":"MJ Pajares","year":"2007","unstructured":"Pajares MJ, Ezponda T, Catena R, Calvo A, Pio R, Montuenga LM et al. Alternative splicing: an emerging topic in molecular and clinical oncology. Lancet Oncol 2007; 8: 349\u2013357.","journal-title":"Lancet Oncol"},{"key":"BFonc2014230_CR35","doi-asserted-by":"publisher","first-page":"e1002731","DOI":"10.1371\/journal.pgen.1002731","volume":"8","author":"I Simeonova","year":"2012","unstructured":"Simeonova I, Lejour V, Bardot B, Bouarich-Bourimi R, Morin A, Fang M et al. Fuzzy tandem repeats containing p53 response elements may define species-specific p53 target genes. PLoS Genet 2012; 8: e1002731.","journal-title":"PLoS Genet"},{"key":"BFonc2014230_CR36","volume-title":"Afip - Laboratory Methods in HIstotechnology","author":"E Prophet","year":"1992","unstructured":"Prophet E, Mills B, Arrington J, Sobin L . Afip - Laboratory Methods in HIstotechnology. American Registry of Pathology: Washington, DC, USA, 1992."},{"key":"BFonc2014230_CR37","first-page":"1839","volume":"61","author":"YF Ramos","year":"2001","unstructured":"Ramos YF, Stad R, Attema J, Peltenburg LT, van der Eb AJ, Jochemsen AG . et al. Aberrant expression of HDMX proteins in tumor cells correlates with wild-type p53. Cancer Res 2001; 61: 1839\u20131842.","journal-title":"Cancer Res"},{"key":"BFonc2014230_CR38","doi-asserted-by":"publisher","first-page":"E68","DOI":"10.1093\/nar\/29.13.e68","volume":"29","author":"II Vandenbroucke","year":"2001","unstructured":"Vandenbroucke II, Vandesompele J, Paepe AD, Messiaen L . Quantification of splice variants using real-time PCR. Nucleic Acids Res 2001; 29: E68\u2013E68.","journal-title":"Nucleic Acids Res"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2014230.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2014230","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2014230.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T20:12:18Z","timestamp":1647893538000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2014230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,4]]},"references-count":38,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2015,5,28]]}},"alternative-id":["BFonc2014230"],"URL":"https:\/\/doi.org\/10.1038\/onc.2014.230","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,4]]},"assertion":[{"value":"21 January 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}